Skip to content

Randomised controlled trial of surgical treatment of varicose veins in legs: Stripping versus Conservative Treatment (CHIVA)

Randomised controlled trial of surgical treatment of varicose veins in legs: Stripping versus Conservative Treatment (CHIVA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN52861672
Enrollment
501
Registered
2005-04-13
Start date
1998-02-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose veins in legs Circulatory System Varicose veins

Interventions

Stripping with clinic marking, Stripping with Eco-Doppler marking, Conservative Treatment (CHIVA)

Sponsors

Spanish Ministry of Health, Investigation of Sanitary Funding (Fondo de Investigación Sanitaria Ministerio de Sanidad y Consumo)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients affected by varicose veins of the lower extremities. Added 23/11/2015: The study included patients diagnosed with primary varicose veins in an external consultation by a vascular surgeon, according to the CEAP (CA-S, 2–6; EP; AS, P; PR; LII) classification criteria and with permeable, continent deep venous system upon duplex ultrasonography exploration. In patients with varicose veins in both extremities, only 1 limb could be randomized.

Exclusion criteria

Exclusion criteria: Patients previously operated for varicose veins with recurrent varicose veins will be excluded. Added 23/11/2015: All patients with congenital venous disease, varicose veins secondary to prior deep vein thrombosis, postphlebitic side-effects, sclerotherapy, relapse of varicose veins after surgery, associated systemic pathologies, or who refused to participate in the study, refused surgical treatment, were not ambulatory, could not participate in long-term follow-up or had been pregnant less than 6 months previously were excluded from the study.

Design outcomes

Secondary

MeasureTime frame
1. Time until medical discharge 2. Clinical and haemodynamic improvement 3. Satisfaction rate 4. Cost for each group

Primary

MeasureTime frame
The clinic and haemodynamic determination of the recurrences number and the time between the intervention and recurrence will be calculated.

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 31, 2026